Fertin Pharma

Tobacco manufacturer Philip Morris International (PMI) has announced the acquisition of Fertin Pharma for DKK 5.1 billion (approximately USD 820 million). Fertin Pharma is a leading developer and manufacturer of innovative pharmaceutical and well-being products, specializing in the research, development and production of gums, pouches, liquefiable tablets, and other solid oral systems for the delivery of active ingredients, including nicotine. The company has more than 850 employees in its facilities …